ARENA PHARMACEUTICALS INC Insider Trading for March 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARENA PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ARENA PHARMACEUTICALS INC for March 2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Stelzer Laurie | EVP & Chief Financi ... | Option Exercise | A | 0.00 | 15,200 | 0 | 15,200 | |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Stelzer Laurie | EVP & Chief Financi ... | Option Exercise | A | 80.08 | 38,850 | 3,111,108 | 38,850 | |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Stelzer Laurie | EVP & Chief Financi ... | Grant | A | 0.00 | 6,660 | 0 | 6,660 | 0 to 6.7 K |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Option Exercise | A | 0.00 | 42,000 | 0 | 42,000 | |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Option Exercise | A | 80.08 | 168,000 | 13,453,440 | 168,000 | |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Munshi Amit | President and CEO | Grant | A | 0.00 | 28,800 | 0 | 36,550 | 7.8 K to 36.6 K (+371.61 %) |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Schmidt Joan | EVP, General Counse ... | Option Exercise | A | 0.00 | 15,200 | 0 | 15,200 | |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Schmidt Joan | EVP, General Counse ... | Option Exercise | A | 0.00 | 15,200 | 0 | 15,200 | |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Schmidt Joan | EVP, General Counse ... | Option Exercise | A | 80.08 | 38,850 | 3,111,108 | 38,850 | |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Schmidt Joan | EVP, General Counse ... | Option Exercise | A | 80.08 | 38,850 | 3,111,108 | 38,850 | |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Schmidt Joan | EVP, General Counse ... | Grant | A | 0.00 | 6,660 | 0 | 6,875 | 215 to 6.9 K (+3,097.67 %) |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Schmidt Joan | EVP, General Counse ... | Grant | A | 0.00 | 6,660 | 0 | 6,875 | 215 to 6.9 K (+3,097.67 %) |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Option Exercise | A | 0.00 | 15,200 | 0 | 15,200 | |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Option Exercise | A | 0.00 | 15,200 | 0 | 15,200 | |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Option Exercise | A | 80.08 | 38,850 | 3,111,108 | 38,850 | |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Option Exercise | A | 80.08 | 38,850 | 3,111,108 | 38,850 | |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Grant | A | 0.00 | 6,660 | 0 | 16,101 | 9.4 K to 16.1 K (+70.54 %) |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Lisicki Robert | EVP, Chief Commerci ... | Grant | A | 0.00 | 6,660 | 0 | 16,101 | 9.4 K to 16.1 K (+70.54 %) |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | A | 0.00 | 15,200 | 0 | 15,200 | |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | A | 0.00 | 15,200 | 0 | 15,200 | |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | A | 80.08 | 38,850 | 3,111,108 | 38,850 | |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Option Exercise | A | 80.08 | 38,850 | 3,111,108 | 38,850 | |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Grant | A | 0.00 | 6,660 | 0 | 33,660 | 27 K to 33.7 K (+24.67 %) |
Mar 03 2021 | ARNA | ARENA PHARMACEUTIC ... | Aurentz Vincent | Executive VP and CB ... | Grant | A | 0.00 | 6,660 | 0 | 33,660 | 27 K to 33.7 K (+24.67 %) |